Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study-Reference-Cited by-同舟云学术

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Published:2010-11-11 Issue:4 Volume:18 Page:354-363
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Westermann J,Flörcken A,Willimsky G,van Lessen A,Kopp J,Takvorian A,Jöhrens K,Lukowsky A,Schönemann C,Sawitzki B,Pohla H,Frank R,Dörken B,Schendel D J,Blankenstein T,Pezzutto A

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt2010143.pdf

Reference51 articles.

1. Mocellin S, Mandruzzato S, Bronte V, Lise M, Nitti D . Part I: vaccines for solid tumors. Lancet Oncol 2004; 5: 681–689.

2. De Gruijl TD, van den Eertwegh AJM, Pinedo HM, Scheper RJ . Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol Immunother 2008; 57: 1569–1577.

3. Fournier P, Schirrmacher V . Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. Exper rev Vaccines 2009; 8: 51–66.

4. Sobol RE . The rationale for prophylactic cancer vaccines and need for a paradigm shift. Cancer Gene Ther 2006; 13: 725–731.

5. Finn OJ . Cancer vaccines: between the idea and the reality. Nat Rev Immunol 2003; 3: 630–641.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?;Frontiers in Immunology;2022-10-28

2. Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions;International Journal of Molecular Sciences;2022-04-15

3. Tumorvakzinierung –Strategien und Timing;Der Internist;2021-08-16

4. Tumorvakzinierung –Strategien und Timing;Der Gastroenterologe;2021-06-15

5. Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer;Cancer Immunology, Immunotherapy;2018-03-29